Estadísticas de Renal Outcomes of GLP‑1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/ Obesity): A Scoping Review
Visitas totales
| views | |
|---|---|
| Renal Outcomes of GLP‑1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/ Obesity): A Scoping Review | 6 |
Visitas totales por mes
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 6 |
Visitas de archivo
| views | |
|---|---|
| PDF.pdf | 9 |
Vistas principales por país
| views | |
|---|---|
| Colombia | 5 |
| Mexico | 1 |
Visitas principales por ciudad
| views | |
|---|---|
| Benito Juarez | 1 |